Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
42.90
+0.51 (1.20%)
Oct 20, 2025, 4:00 PM EDT - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $5.57 billion as of October 20, 2025. Its market cap has decreased by -60.59% in one year.
Market Cap
5.57B
Enterprise Value
3.93B
1-Year Change
-60.59%
Ranking
Category
Stock Price
$42.90
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $5.57B, an increase of 303.59%. That is a compound annual growth rate of 29.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 5.50B | -46.06% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |